Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2001 2
2002 2
2005 2
2006 1
2007 3
2008 9
2009 14
2010 28
2011 15
2012 31
2013 38
2014 22
2015 27
2016 24
2017 24
2018 24
2019 21
2020 7
2021 16
2022 13
2023 6
2024 14
2025 12
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Novel pharmacological targets for GABAergic dysfunction in ADHD.
Ferranti AS, Luessen DJ, Niswender CM. Ferranti AS, et al. Among authors: niswender cm. Neuropharmacology. 2024 May 15;249:109897. doi: 10.1016/j.neuropharm.2024.109897. Epub 2024 Mar 8. Neuropharmacology. 2024. PMID: 38462041 Free PMC article. Review.
GRM7 gene mutations and consequences for neurodevelopment.
Freitas GA, Niswender CM. Freitas GA, et al. Among authors: niswender cm. Pharmacol Biochem Behav. 2023 Apr;225:173546. doi: 10.1016/j.pbb.2023.173546. Epub 2023 Mar 30. Pharmacol Biochem Behav. 2023. PMID: 37003303 Free PMC article. Review.
A Coordinated Attack: Rett Syndrome Therapeutic Development.
Gogliotti RG, Niswender CM. Gogliotti RG, et al. Among authors: niswender cm. Trends Pharmacol Sci. 2019 Apr;40(4):233-236. doi: 10.1016/j.tips.2019.02.007. Trends Pharmacol Sci. 2019. PMID: 30905360 Free PMC article. Review.
MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome.
Dennys CN, Vermudez SAD, Deacon RJM, Sierra-Delgado JA, Rich K, Zhang X, Buch A, Weiss K, Moxley Y, Rajpal H, Espinoza FD, Powers S, Ávila AS, Gogliotti RG, Cogram P, Niswender CM, Meyer KC. Dennys CN, et al. Among authors: niswender cm. Neurotherapeutics. 2024 Sep;21(5):e00376. doi: 10.1016/j.neurot.2024.e00376. Epub 2024 Jun 14. Neurotherapeutics. 2024. PMID: 38876822 Free PMC article.
mGluR7's lucky number.
Conn PJ, Niswender CM. Conn PJ, et al. Among authors: niswender cm. Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):251-2. doi: 10.1073/pnas.0510051103. Epub 2006 Jan 3. Proc Natl Acad Sci U S A. 2006. PMID: 16407154 Free PMC article. No abstract available.
Discovery of VU6024578/BI02982816: An mGlu1 Positive Allosteric Modulator with Efficacy in Preclinical Antipsychotic and Cognition Models.
Reed CW, Kalbfleisch JF, Turkett JA, Trombley TA, Nastase AF, Spearing PK, Haymer DH, Sarwar MM, Quitalig M, Dickerson JW, Blobaum AL, Boutaud O, Voehringer P, Schuelert N, Cho HP, Niswender CM, Rook JM, Priepke H, Ursu D, Conn PJ, Melancon BJ, Lindsley CW. Reed CW, et al. Among authors: niswender cm. J Med Chem. 2024 Dec 26;67(24):22291-22312. doi: 10.1021/acs.jmedchem.4c02554. Epub 2024 Dec 12. J Med Chem. 2024. PMID: 39665415 Free PMC article.
Trofinetide: a pioneering treatment for Rett syndrome.
Parent H, Ferranti A, Niswender C. Parent H, et al. Among authors: niswender c. Trends Pharmacol Sci. 2023 Oct;44(10):740-741. doi: 10.1016/j.tips.2023.06.008. Epub 2023 Jul 16. Trends Pharmacol Sci. 2023. PMID: 37460385 Free PMC article.
287 results